In collaboration with the Korea Health Association, the number one health screening institution in Korea,

Biotech companies are leveraging empirical research and medical data to

To verify the clinical validity of the technology,

You can precisely adjust the direction of R&D.

This increases the applicability in real medical environments,

Maximize your commercialization success rate with reliable data-based solutions.